Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Nature Communications|April 7, 2022
Enabling fast-charging selenium-based aqueous batteries via conversion reaction with copper ionsChunlong Dai, Linyu Hu, Hao Chen, et al.
Cancer Research|February 28, 2016
Intracellular Released Payload Influences Potency and Bystander-Killing Effects of Antibody-Drug Conjugates in Preclinical ModelsFu Li, Kim K Emmerton, Mechthild Jonas, et al.
Science Advances|July 20, 2022
Fast constructing polarity-switchable zinc-bromine microbatteries with high areal energy densityChunlong Dai, Linyu Hu, Xuting Jin, et al.
Bioconjugate Chemistry|May 18, 2006
Development and properties of beta-glucuronide linkers for monoclonal antibody-drug conjugatesScott C Jeffrey, Jamie B Andreyka, Starr X Bernhardt, et al.
ACS Medicinal Chemistry Letters|July 16, 2025
Auristatin S: An Auristatin Payload with Improved Tolerability and Modified Bystander ActivityPhilip N Moquist, Nicole M-L Eng-Duncan, Tim D Bovee, et al.
Molecular Cancer Therapeutics|August 30, 2008
Anti-CD30 diabody-drug conjugates with potent antitumor activityKristine M Kim, Charlotte F McDonagh, Lori Westendorf, et al.
Nature Biotechnology|May 29, 2019
A coiled-coil masking domain for selective activation of therapeutic antibodiesVivian H Trang, Xinqun Zhang, Roma C Yumul, et al.
Oncogene|October 9, 2002
Characterization of KLK4 expression and detection of KLK4-specific antibody in prostate cancer patient seraCraig H Day, Gary R Fanger, Marc W Retter, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2013
Development of orally active inhibitors of protein and cellular fucosylationNicole M Okeley, Stephen C Alley, Martha E Anderson, et al.
Bioconjugate Chemistry|May 24, 2024
Reversible Chemical Modification of Antibody Effector Function Mitigates Unwanted Systemic Immune ActivationPhilip N Moquist, Xinqun Zhang, Chris I Leiske, et al.
Pageof 4